Literature DB >> 17712004

Quantification of diphtheria toxin mediated ADP-ribosylation in a solid-phase assay.

Christopher Bachran1, Mark Sutherland, Diana Bachran, Hendrik Fuchs.   

Abstract

BACKGROUND: Because of reduced vaccination programs, the number of diphtheria infections has increased in the last decade. Diphtheria toxin (DT) is expressed by Corynebacterium diphtheriae and is responsible for the lethality of diphtheria. DT inhibits cellular protein synthesis by ADP-ribosylation of the eukaryotic elongation factor 2 (eEF2). No in vitro system for the quantification of DT enzymatic activity exists. We developed a solid-phase assay for the specific detection of ADP-ribosylation by DT.
METHODS: Solid phase-bound his-tag eEF2 is ADP-ribosylated by toxins using biotinylated NAD(+) as substrate, and the transferred biotinylated ADP-ribose is detected by streptavidin-peroxidase. DT enzymatic activity correlated with absorbance. We measured the amount of ADP-ribosylated eEF2 after precipitation with streptavidin-Sepharose. Quantification was done after Western blotting and detection with anti-his-tag antibody using an LAS-1000 System.
RESULTS: The assay detected enzymatically active DT at 30 ng/L, equivalent to 5 mU/L ADP-ribosylating activity. Pseudomonas exotoxin A (PE) activity was also detected at 100 ng/L. We verified the assay with chimeric toxins composed of the catalytic domain of DT or PE and a tumor-specific ligand. These chimeric toxins revealed increased signals at 1000 ng/L. Heat-inactivated DT and cholera toxin that ADP-ribosylates G-proteins did not show any signal increase.
CONCLUSIONS: The assay may be the basis for the development of a routine diagnostic assay for the detection of DT activity and highly specific inhibitors of DT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712004     DOI: 10.1373/clinchem.2007.085365

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   12.167


  7 in total

1.  The toxin component of targeted anti-tumor toxins determines their efficacy increase by saponins.

Authors:  Alexander Weng; Mayank Thakur; Figen Beceren-Braun; Diana Bachran; Christopher Bachran; Sebastian B Riese; Kristina Jenett-Siems; Roger Gilabert-Oriol; Matthias F Melzig; Hendrik Fuchs
Journal:  Mol Oncol       Date:  2012-01-24       Impact factor: 6.603

Review 2.  The bacterial instrument as a promising therapy for colon cancer.

Authors:  Atieh Yaghoubi; Majid Khazaei; Amir Avan; Seyed Mahdi Hasanian; Saman Soleimanpour
Journal:  Int J Colorectal Dis       Date:  2020-03-04       Impact factor: 2.571

Review 3.  Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.

Authors:  Andre Cassell; Jennifer R Grandis
Journal:  Expert Opin Investig Drugs       Date:  2010-06       Impact factor: 6.206

4.  Reductive methylation and mutation of an anthrax toxin fusion protein modulates its stability and cytotoxicity.

Authors:  Christopher Bachran; Pradeep K Gupta; Silke Bachran; Clinton E Leysath; Benjamin Hoover; Rasem J Fattah; Stephen H Leppla
Journal:  Sci Rep       Date:  2014-04-23       Impact factor: 4.996

5.  The NarE protein of Neisseria gonorrhoeae catalyzes ADP-ribosylation of several ADP-ribose acceptors despite an N-terminal deletion.

Authors:  Paula I Rodas; A Said Álamos-Musre; Francisca P Álvarez; Alejandro Escobar; Cecilia V Tapia; Eduardo Osorio; Carolina Otero; Iván L Calderón; Juan A Fuentes; Fernando Gil; Daniel Paredes-Sabja; Myron Christodoulides
Journal:  FEMS Microbiol Lett       Date:  2016-07-26       Impact factor: 2.742

6.  Anthrax toxin-mediated delivery of the Pseudomonas exotoxin A enzymatic domain to the cytosol of tumor cells via cleavable ubiquitin fusions.

Authors:  Christopher Bachran; Thomas Morley; Suzanne Abdelazim; Rasem J Fattah; Shihui Liu; Stephen H Leppla
Journal:  mBio       Date:  2013-04-30       Impact factor: 7.786

7.  Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus.

Authors:  Marta Borowiec; Michal Gorzkiewicz; Joanna Grzesik; Aurelia Walczak-Drzewiecka; Anna Salkowska; Ewelina Rodakowska; Kamil Steczkiewicz; Leszek Rychlewski; Jaroslaw Dastych; Krzysztof Ginalski
Journal:  Toxins (Basel)       Date:  2016-11-10       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.